It is expressed exclusively on lymphocytes and particularly on effector and regulatory CD4+ T cells, effector CD8+ T cells, and natural killer (NK) cells.12 Like CTLA‐4 and PD‐1, TIGIT is a negative checkpoint of the tumor immune response. The gene discussed is TIGIT; the disease is neoplasm.